Aliath is now signatory to the Impact Principles!The Impact Principles are a framework for investors for the design and implementation of their impact management systems,ensuring that impact considerations are integrated throughout the investment lifecycle.https://t.co/V9h6jtTIDs
Et convidem a conèixer tot el que ha donat de si aquest mes de març a la #BioRegió!
🏩 Continua l'aposta per ubicar nous centres a #Barcelona, es tanquen noves operacions d’#inversió, avenços en el ‘pipeline’ i més!
🔗 https://t.co/xKhN4e199d
¡Te invitamos a conocer todo lo que ha dado de sí este mes de marzo en la #BioRegión!
🏩 Continúa la apuesta por ubicar nuevos centros en #Barcelona, se cierran nuevas operaciones de #inversión, avances en el pipeline, ¡y más!
🔗 https://t.co/gyWUoJIU2u
Let’s look back at everything that happened in March in the #BioRegion!
🏩 Large pharmaceutical corporations continue to choose #Barcelona for their new centers, new #investment operations have been closed, advances in the pipeline, and more!
🔗 https://t.co/UbZ6MsiFpB
➡️ @Mediktor Co-Founder & CEO @cpascualf 's new article in @HCBizToday provides an overview of the role #artificialintelligence chatbots & assisted decision-making technologies can play in improving access to care for all. Read it today.
https://t.co/He4do5AUlX #healthequity
Mediktor's AI mproves hospital's triage process and patient outcomes. It rapidly assesses symptoms and recommends care in minutes. Book a demo and have it up and running in less than 4 weeks! https://t.co/4drMG3zglE
Mediktor is attending #INFORSALUD23! Meet there Ernest Sarrias, from our Global Business Development team. Don't miss the opportunity to contact him and learn more about how Mediktor is revolutionizing access to healthcare globally.
#AltamarCAM registra en la @CNMV_MEDIOS su segundo fondo de venture capital, ACP Aliath Bioventures II FCR (ABV II), que invertirá en compañías del sector de la salud
https://t.co/q1yyEEe5A9 #Altamar#biotecnologia#ESG#fondo
Nuevo impulso a la biotecnología española. AltamarCam se alía con directivos @_AltaLS para lanzar Aliath Bioventures. El nuevo fondo tiene un objetivo de 150M€. Los detalles, en @expansioncom
https://t.co/0Djp7UQzUe